Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
T. Jeeraaumponwat (Khon Kaen, Thailand). N-acetylcysteine and mortality in hospitalized pulmonary tuberculosis infection. 2958

Member's Comments

No comment yet.

Related content which might interest you: Analysis of mortality incidence in patients with pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 555s Year: 2002 Risk factors of intrahospital mortality for pulmonary tuberculosis Source: Annual Congress 2007 - Clinical epidemiology of tuberculosis Year: 2007 Epidemiological features of nosocomial tuberculosis in patients with pulmonary tuberculosis in TB hospital Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018 Survival and risk factors of mortality among defaulters from treatment of pulmonary tuberculosis Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012 COPD is associated with increased mortality in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: 346-351 Year: 2006 Mycobacterial non-tuberculosis infection in patients operated on for pulmonary tuberculosis Source: Virtual Congress 2020 – Thoracic surgery: lung cancer and infectious disease Year: 2020 Risk factors for pulmonary tuberculosis in community-acquired pneumonia Source: Eur Respir J 2014; 43: 1213 Year: 2014 Risk factors for pulmonary tuberculosis in community-acquired pneumonia Source: Eur Respir J 2014; 43: 1214 Year: 2014 Prevalence of CNS lesions in patients with pulmonary tuberculosis and HIV infection Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019 Inflammatory responses predict long-term mortality risk in community-acquired pneumonia Source: Eur Respir J 2011; 37: 1439-1446 Year: 2011 Pulmonary and extrapulmonary morbidity and mortality in COPD Source: School Course 2012 - Clinical challenges in COPD: a bedside teaching course Year: 2012 Increased detection of pulmonary tuberculosis amongst hospitalised inpatients during the COVID-19 pandemic Source: Eur Respir J, 57 (5) 2100616; 10.1183/13993003.00616-2021 Year: 2021 Lymphopenia as a mortality predictor in non HIV pulmonary TB patients Source: Eur Respir J 2004; 24: Suppl. 48, 424s Year: 2004 The incidence of pulmonary infection caused by atypical pathogens in non-HIV immunocompromised patients Source: Annual Congress 2010 - Unusual pathogens in respiratory infections Year: 2010 Latent tuberculosis infection in children in contact with pulmonary tuberculosis patients Source: Annual Congress 2010 - Tuberculosis in children Year: 2010 The prevalence and clinical profile of non-tuberculous mycobacterial pulmonary infection in Singapore Source: International Congress 2018 – Respiratory epidemiology:  from infectious diseases to lung cancer Year: 2018 Predictors of mortality in chronic pulmonary aspergillosis Source: Eur Respir J , 49 (2) 1601062; DOI: 10.1183/13993003.01062-2016 Year: 2017 Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease Source: Eur Respir J, 51 (1) 1701578; 10.1183/13993003.01578-2017 Year: 2018 Pulmonary tuberculosis with acute respiratory failure Source: Eur Respir J 2008; 32: 1625-1630 Year: 2008